NCT07597980

Brief Summary

The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance. The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise. The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise. Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week. Pre and post-intervention, body composition, physical function, and energy deficit will be measured.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
55mo left

Started Jun 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

4.5 years

First QC Date

May 8, 2026

Last Update Submit

May 14, 2026

Conditions

Keywords

Fat massmuscle massphysical functionenergy deficit

Outcome Measures

Primary Outcomes (1)

  • Fat mass

    Fat mass measured by dual X-ray absorptiometry

    Change from baseline to 12 weeks

Secondary Outcomes (10)

  • Skeletal muscle mass

    Change in from baseline to 12 weeks

  • Short physical performance battery

    Change from baseline to 12 weeks

  • Hand-grip strength

    Change from baseline to 12 weeks

  • Knee strength

    Change from baseline to12 weeks

  • Energy stores

    12 weeks

  • +5 more secondary outcomes

Study Arms (2)

Structured nutrition plan + exercise

EXPERIMENTAL

Intervention: Participants receive a structured nutrition plan, and exercise under supervision.

Behavioral: Structured nutrition plan + exercise

Typical or usual diet + exercise

ACTIVE COMPARATOR

Participants receive a typical or usual diet, and exercise under supervision

Other: Typical or usual diet + exercise

Interventions

Participants will receive a structured nutrition plan. The exercise intervention will be the same in both groups.

Structured nutrition plan + exercise

Participants will receive a diet representing the usual diet in this population. The exercise intervention will be the same in both groups.

Typical or usual diet + exercise

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 50 years.
  • Body mass index (BMI) ≥ 30 kg/m2.
  • Homeostatic model assessment of insulin resistance ≥ 3.
  • Mini-Mental State Examination (MMSE) \> 25.
  • Geriatric Depression Scale-15 (GDS-15) \< 9.
  • Sedentary (less than 90 minutes/week of moderate to vigorous activity).
  • Ability to provide written informed consent.

You may not qualify if:

  • Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction.
  • Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers.
  • Fluctuation in body weight \> 3 kg in the preceding two months
  • Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Candida J Rebello, PhD, RD

    Pennington Biomedical Research Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Candida J Rebello, PhD, RD

CONTACT

Reilly Roberts A Project Manager, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 8, 2026

First Posted

May 20, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

At this time, we do not have plans to share IPD. We may consider it after the study results have been publicly disseminated

Locations